Member Info for bignose58

Finally after years of realisation that she has no experience in Pharma, Julie Oates has left to get her Oats elsewhere, although god knows what she did in the company apart from get paid.

And what do they do with an opportunity to right their wrongs and employ someone with relevant background, they employ someone with a mainly engineering background who’s names resembles a bottle of wine, Al Chalabi.

What’s the matter with these people ? Surely they must have realised by now the company desperately needs talent with Pharma experience. Maybe they employed him because they think the company is going to fly after Chinese submission……oh dear, oh dear….

H,

I certainly am not an HSBC trader, in fact nothing to do with my profession when I worked. Pure guesswork on your side I’m afraid, but all means keep trying.

Amazingly, it was up over 25% and a couple of 10single lot sells brings it back down with a thump. At least the sp managed to hold on to 11%.

Could this just be a low volume pump and dump (if there is such a thing) heading into the mid term results, what say you H ?

The.Italian,

You were not wrong. A sudden rise and right on cue, Heimdal enters stage left.

Let’s all give it up for Heimdal…clap, clap, clap….hoooorrraaahhh.

Ripely,

You may want to consider dipping a toe in FUM since their mid-term results are due in Sept which could give a sudden boost, although maybe risky given the US license agreement held no juice, however. One would expect in the long term the sp could do well as more license agreements are signed and first impressions are that the product is definitely giving Viagra and Cialis a run for their money which, in a multi-billion dollar market, cannot be ignored.

Morning The.Italian.

No problem, the guy obviously hasn't read any of your posts. He doesn't even know if you are supposedly ramping or deramping. A complete dcik

Ripely, there are no other less experienced investors who post here. The only ones who do are hardened investors (except 1) who have followed the stock since the Ple takeover at the beginning of 2016. The majority of investors outside of the A team are those residing in HK or mainland China and then those that have posted here have turned out to be English speaking HK traders who think they can manipulate the stock when they are involved in pumps and dumps, however. Given how the free float is now a lot less, I would suspect that it’s become more difficult for them to even do that.

Toli,

So his 6,936 have all been posts about FUM. A share he has never been invested in? I suggest you go away and do some homework before posting such absurd statements otherwise you will just show yourself to be completely incompetent.

That should read as “Would not want to attract attention”.

Morning The.Italian,

It is anyone's guess given past history, however. Since it has basically risen everyday for the last week. One cannot ignore some news has been leaked, particularly since only small volumes are involved. This certainly could support positive news because any one buying would want to attract attention to themselves with reduced free float of shares and the consequences of significant rises on any large buys. All speculation on my part, but something is a foot.

I see Saudi may have received approval for Eroxon, although there doesn't appear to be an RNS about it yet. The SP certainly appears to being held back. With the recent news one would still expect a small rise instead of stagnation.

Well a 10k share sell and up she pops 11%. It would seem the current level is around 1 HK Dorrar.....lol.

There has got to be news released soon...... even bad news, although from the recent rise, it surely has to be good. :-)

Probably why it’s still not on sale in China where there are between 175 to 200 mill sufferers. The market cap would be much higher if they had gotten approval which surely wouldn’t take 2 years when no drugs are involved.

Well someone must be kicking themselves as it closed abt 18.5% lower than they paid. Certainly not conducive to make new investors jump in. Of course, whoever it was will still make money on the news, but they could have been 18% better off……lol

I should think definitely China approval next year, however. I wouldn't bet my life on FDA approval in the next couple of years given the historic incompetence of those involved. Of course, my view could possibly change if the reigns of the approval process were handed over to a licensee with clout, but given no one has wanted to commit after all these years of allusions, why would it be any different now, even with a SPA. It's not like the sales exercise did anything to help, did it ?

Granted. One could argue some of it was under the Endurance heading, however. It was all initiated by Regent who just passed the hat and have taken it back again....

Reasons for the Change of Company Name

The Board considers that the change of Company name back to “Regent Pacific Group Limited” is more appropriate as the

current name has led to confusion of the Company’s image and brand among its key stakeholders, and furthermore the current name is failing to stand out. The Board, therefore, considers that reverting back to its original name will more accurately reflect its business and future direction.

Certainly all a bit questionable.... Which key stakeholders want the name change? There is only one and he's the one who initiated the change in the first place. "Failing to stand out" surely Regents past history for misleading shareholders. missing all their own milestones and failing to get the product FDA approved in a timely manner, due to incompetence, is something they really wouldn't want to draw attention to...... :-O.....lol

Given the rise today, keep them peeled for any announcement activity this evening (HK time). Pure speculation on my part, but why not given the recent rise……it could be a possibility ;-)

For a short moment it even touched the dizzy heights of 19+%, yet suddenly dropped back to 9%. Certainly some heavy swings on low low volumes....

Well another 13% rise as I write, plus the other 3 days of constant rises and contrary to my historic expectations. This surely could make one think there has been a leak of positive information (on purpose given the few number of employees in HK who would be willing to risk exposure? ).

It certainly makes one wonder if there will be an update prior to the interims being released. I certainly would play my hand on the China submission (more likely since we then wait 9 month to a year, if not sooner, for a positive result) or the Result of the FDA phase II closure and issuance of a SPA. (mind you, we would still have to wait maybe 3 years before there is any sign of FDA approval which could be even longer given its taken 5 years for the phase II to be closed out. And of course there is still a big IF regarding that one).

Interesting next few days or weeks.

Well another 4 % rise today. I wonder if the expected news on the China submission is causing the MnMs to slowly increase the price. Unfortunately it’s very difficult to call given the large swings on such Low volumes, however. Something’s gotta give sooner or later……but which way will it go…..flip !!!